Skip to main content
. Author manuscript; available in PMC: 2022 Jul 1.
Published in final edited form as: Am J Kidney Dis. 2021 Jan 1;78(1):75–84.e1. doi: 10.1053/j.ajkd.2020.11.014

Table 1:

Baseline characteristics by sTNFR1 tertiles.

Characteristic Tertile 1
n=167
Tertile 2
n=167
Tertile 3
n=166
p-value
Range, pg/mL 1,267 to 2,372 2,374 to 3,428 3,445 to 9,168
Age, years 58.1 ± 9.0 53.1 ± 10.6 51.0 ± 10.9 <0.001
Female 67 (40%) 64 (38%) 56 (34%) 0.46
APOL1 risk status
Low 92 (82%) 83 (71%) 71 (68%) 0.05
High 20 (18%) 34 (29%) 33 (32%)
% European ancestry 17.9 ± 15.2 14.6 ± 10.6 17.8 ± 11.8 0.09
Years of hypertension 14.4 ± 9.8 14.5 ± 9.5 13.2 ± 10.5 0.40
History of heart disease 87 (52%) 90 (54%) 75 (45%) 0.24
Systolic BP, mm Hg 149 ± 25 152 ± 25 153 ± 23 0.39
BMI, kg/m2 30.1 ± 5.7 31.5 ± 6.4 31.0 ± 7.3 0.11
Current smoking 40 (24%) 44 (26%) 48 (29%) 0.59
GFR, ml/min/1.73 m2 54.7 ± 7.7 47.7 ± 9.1 31.7 ± 8.0 <0.001
Urine PCR, g/g 0.03
(0.02 to 0.06)
0.10
(0.03 to 0.32)
0.37
(0.12 to 0.99)
<0.001
hsCRP, mg/dL 0.32
(0.16 to 0.71)
0.50
(0.24 to 0.97)
0.46
(0.18 to 0.91)
0.01
sTNFR2, pg/mL 8,651
(7,487 to 9,884)
13,042
(10,962 to 14,735)
18,972
(15,936 to 22,917)
<0.001
TNF-α, pg/mL 2.40
(1.78 to 2.92)
3.03
(2.27 to 3.93)
3.74
(2.67 to 4.95)
<0.001
IFN-γ, pg/mL 5.23
(3.72 to 7.55)
5.55
(3.73 to 9.01)
5.73
(3.95 to 11.68)
0.12
suPAR, pg/mL 3,468
(2,821 to 4,334)
4,463
(3,352 to 5,583)
5,561
(4,618 to 7,116)
<0.001
Log2(sTNFR2) 13.07 ± 0.32 13.65 ± 0.32 14.24 ± 0.39 <0.001
Log2(TNF-α) 1.23 ± 0.61 1.56 ± 0.60 1.90 ± 0.67 <0.001
Log2(IFN-γ) 2.47 ± 0.86 2.67 ± 1.15 2.86 ± 1.43 0.01
Log2(suPAR) 11.69 ± 0.61 12.11 ± 0.57 12.47 ± 0.55 <0.001
BP goal
Intensive 87 (52%) 79 (47%) 84 (51%) 0.67
Standard 80 (48%) 88 (53%) 82 (49%)
Drug group
Ramipril 69 (41%) 59 (35%) 67 (40%) 0.70
Metoprolol 69 (41%) 70 (42%) 67 (40%)
Amlodipine 29 (17%) 38 (23%) 32 (19%)

Data presented as mean ± standard deviation; number (percent); median (interquartile range).

Abbreviations: BP=blood pressure; BMI=body mass index; GFR=glomerular filtration rate; PCR=protein-to-creatinine ratio; hsCRP=high-sensitivity c-reactive protein; sTNFR1=soluble tumor necrosis factor receptor 1; sTNFR2=soluble tumor necrosis factor receptor 2; TNF-α=tumor necrosis factor alpha; IFN-γ=interferon gamma; suPAR=soluble urokinase-type plasminogen activator receptor.

Data missing for the following variables: APOL1 (n=167); European ancestry (n=167); Years of hypertension (n=3); suPAR (n=14); log2(suPAR) (n=14)